EcoDrugPlus

Ensembl ID : ENSLBEG00000017824
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSLBEG00000000313
Gene Symbol: -
Cross references: -
4 Possible Orthologues:

Ensembl ID : ENSLBEG00000008905
Gene Symbol: -
Cross references: -
134 Possible Orthologues:

Ensembl ID : ENSLBEG00000027032
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSLBEG00000025298
Gene Symbol: -
Cross references: -
126 Possible Orthologues:

Ensembl ID : ENSLBEG00000025310
Gene Symbol: -
Cross references: -
199 Possible Orthologues:

Ensembl ID : ENSLBEG00000000255
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSLBEG00000003310
Gene Symbol: -
Cross references: -
191 Possible Orthologues:

Ensembl ID : ENSLBEG00000000287
Gene Symbol: -
Cross references: -
207 Possible Orthologues:

Ensembl ID : ENSLBEG00000012912
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSLBEG00000019505
Gene Symbol: -
Cross references: -
268 Possible Orthologues:

Ensembl ID : ENSLBEG00000019366
Gene Symbol: -
Cross references: -
268 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).